Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 10/20 | 0.65 |
| ▸ | MTNR1B | P49286 | 9/20 | 0.65 |
| ▸ | NQO2 | P16083 | 4/20 | 0.65 |
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | BLM | P54132 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | CDK2 | P24941 | 1/20 | 0.49 |
| ▸ | DNA2 | P51530 | 1/20 | 0.49 |
| ▸ | CASP6 | P55212 | 1/20 | 0.49 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30580934 | 1.00 | MTNR1A (0.65) | MTNR1AMTNR1BNQO2MAPTCYP1A2 | |
| SCHEMBL14907362 | 0.82 | MTNR1A (0.72) | MTNR1AMTNR1BMAPTCYP1A2BLM | |
| SCHEMBL30733593 | 0.81 | MTNR1A (0.72) | MTNR1AMTNR1BNQO2MAPTCYP1A2 | |
| SCHEMBL25383376 | 0.81 | MTNR1A (0.72) | MTNR1AMTNR1BNQO2MAPTCYP1A2 | |
| SCHEMBL6920054 | 0.81 | MTNR1A (0.70) | MTNR1AMTNR1BMAPTCYP1A2BLM | |
| SCHEMBL25001887 | 0.81 | MTNR1A (0.56) | MTNR1AMTNR1BNQO2MAPTCYP1A2 | |
| SCHEMBL28964528 | 0.80 | DNA2 (0.53) | MTNR1AMTNR1BNQO2MAPTCDK2 | |
| SCHEMBL26285862 | 0.80 | MTNR1A (0.69) | MTNR1AMTNR1BMAPTCYP1A2BLM | |
| SCHEMBL26451462 | 0.80 | MTNR1A (0.69) | MTNR1AMTNR1BNQO2MAPTCYP1A2 | |
| SCHEMBL17108188 | 0.79 | MTNR1A (1.00) | MTNR1AMTNR1BNQO2CYP1A2BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116782896-A | Nitrifying galectin derivatives and their use for modulating 5-HT2A receptors and treating psychotic disorders | 恩维瑞克生物科学加拿大公司 | 2023-09-19 | — | — | CN | disclosed |
| EP-4208446-A1 | NITRATED PSILOCYBIN DERIVATIVES AND USE THEREOF FOR MODULATING 5-HT2A RECEPTOR AND FOR TREATING A PSYCHIATRIC DISORDER | Enveric Biosciences Canada Inc. (CA) | 2023-07-12 | — | — | EP | disclosed |
| US-20230040398-A1 | NITRATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2023-02-09 | — | — | US | disclosed |
| US-20230040398-A1 | NITRATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230040398-A1 | NITRATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | PNMT, CNR2, NOS2 | MTNR1A 939/4885MTNR1B 162/4885NQO2 347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.